LU92634I2 - Flutémétamol (18f) et ses dérivés pharmaceutiquement acceptables (vizamyl) - Google Patents
Flutémétamol (18f) et ses dérivés pharmaceutiquement acceptables (vizamyl) Download PDFInfo
- Publication number
- LU92634I2 LU92634I2 LU92634C LU92634C LU92634I2 LU 92634 I2 LU92634 I2 LU 92634I2 LU 92634 C LU92634 C LU 92634C LU 92634 C LU92634 C LU 92634C LU 92634 I2 LU92634 I2 LU 92634I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- vizamyl
- flutemetamol
- pharmaceutically acceptable
- acceptable derivatives
- derivatives
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/645,847 US20050043523A1 (en) | 2003-08-22 | 2003-08-22 | Benzothiazole derivative compounds, compositions and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
LU92634I2 true LU92634I2 (fr) | 2015-11-02 |
Family
ID=41568829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU92634C LU92634I2 (fr) | 2003-08-22 | 2015-01-14 | Flutémétamol (18f) et ses dérivés pharmaceutiquement acceptables (vizamyl) |
Country Status (2)
Country | Link |
---|---|
US (3) | US8236282B2 (fr) |
LU (1) | LU92634I2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7270800B2 (en) * | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
RU2324686C2 (ru) * | 2000-08-24 | 2008-05-20 | Юнивесити Оф Питсбэг | ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА |
US8236282B2 (en) * | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
KR102349433B1 (ko) * | 2015-11-27 | 2022-01-10 | 삼성전자주식회사 | 자이로스코프 센서를 제어할 수 있는 이미지 센서와 이를 포함하는 장치들 |
CN109400615B (zh) * | 2017-08-18 | 2021-07-16 | 上海交通大学医学院附属新华医院 | 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用 |
KR102051666B1 (ko) * | 2017-12-07 | 2019-12-04 | 사회복지법인 삼성생명공익재단 | 아밀로이드 페트(pet) 영상을 이용한 알츠하이머 치매의 병기 측정 방법 및 장치 |
KR102649096B1 (ko) * | 2021-11-23 | 2024-03-18 | 연세대학교 산학협력단 | Pet 영상 변환 방법 및 이를 이용한 뇌질환 진단 방법 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU37546A1 (fr) | 1958-08-22 | |||
DE3148291A1 (de) | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
DE3307364A1 (de) | 1983-03-02 | 1984-09-06 | Hoechst Ag, 6230 Frankfurt | Zweikomponenten-diazontypiematerial |
US4933156A (en) | 1987-04-08 | 1990-06-12 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
EP0287909B1 (fr) | 1987-04-08 | 1992-09-02 | Salutar, Inc. | Test diagnostique pour l'amyloidose et la maladie d'Alzheimer et réactif à cet effet |
GB9317949D0 (en) | 1993-08-28 | 1993-10-13 | Stevens Malcolm F G | Benzothiazole compounds |
JPH09511492A (ja) | 1994-02-03 | 1997-11-18 | ザ ピコワー インスティテュート フォア メディカル リサーチ | アミロイドーシスの前進性グリコシル化終末産物仲介モジュレーション用組成物及び方法 |
US6417178B1 (en) | 1994-07-19 | 2002-07-09 | University Of Pittsburgh | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
GB9503946D0 (en) * | 1995-02-28 | 1995-04-19 | Cancer Res Campaign Tech | Benzazole compounds |
AU1529297A (en) | 1996-01-24 | 1997-08-20 | Warner-Lambert Company | Method of imaging amyloid deposits |
JP2001510450A (ja) | 1996-10-23 | 2001-07-31 | ザイモジェネティクス,インコーポレイテッド | 骨欠損状態を処置するための組成物および方法 |
HUP0001383A3 (en) | 1996-11-22 | 2001-11-28 | Lilly Co Eli | N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use |
WO2000002004A2 (fr) | 1998-06-30 | 2000-01-13 | Kevin Mcclung | Projectile a penetration commandee |
GB9919673D0 (en) | 1999-08-20 | 1999-10-20 | Cancer Res Campaign Tech | 2-Arlybenzazole compounds |
RU2324686C2 (ru) | 2000-08-24 | 2008-05-20 | Юнивесити Оф Питсбэг | ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА |
US7270800B2 (en) * | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
EP1345914A1 (fr) | 2000-12-22 | 2003-09-24 | AstraZeneca AB | Composes therapeutiques |
US6696039B2 (en) | 2001-04-23 | 2004-02-24 | Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
GB0229695D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase preparation of 18F-labelled amino acids |
GB0229686D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
US8236282B2 (en) * | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
US8147798B2 (en) * | 2004-07-02 | 2012-04-03 | University of Pittsburgh—of the Commonwealth System of Higher Education | Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
-
2009
- 2009-09-30 US US12/570,379 patent/US8236282B2/en not_active Expired - Lifetime
-
2012
- 2012-07-12 US US13/548,014 patent/US8691185B2/en not_active Expired - Lifetime
-
2014
- 2014-04-07 US US14/246,890 patent/US9134328B2/en not_active Expired - Lifetime
-
2015
- 2015-01-14 LU LU92634C patent/LU92634I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US9134328B2 (en) | 2015-09-15 |
US8691185B2 (en) | 2014-04-08 |
US20100021388A1 (en) | 2010-01-28 |
US8236282B2 (en) | 2012-08-07 |
US20130004422A1 (en) | 2013-01-03 |
US20140220590A1 (en) | 2014-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU92513I2 (fr) | Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi) | |
LU92517I2 (fr) | Delamanide et ses dérivés pharmaceutiquement acceptables | |
LU93093I2 (fr) | Nécitumumab et ses dérivés pharmaceutiquement acceptables (portrazza) | |
LU92419I2 (fr) | Riociguat et ses dérivés pharmaceutiquement acceptables (ADEMPAS®) | |
LU92336I2 (fr) | Trastuzumab emtansine et ses dérivés pharmaceutiquement acceptables (KADCYLA) | |
LU93189I2 (fr) | Ixekizumab et ses dérivés pharmaceutiquement acceptables (TALTZ) | |
LU92381I2 (fr) | Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT) | |
LU92871I2 (fr) | Fumarate de diméthyle et ses dérivés pharmaceutiquement acceptables (tecfidera) | |
LUC00127I2 (fr) | Dacomitinib et ses derives pharmaceutiquement accepatbles ( vizimpro ) | |
LU92634I2 (fr) | Flutémétamol (18f) et ses dérivés pharmaceutiquement acceptables (vizamyl) | |
LU92326I2 (fr) | Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS) | |
LU91883I2 (fr) | Pradofloxacin et ses dérivés pharmaceutiquement acceptables (VERAFLOX®) | |
LU92024I2 (fr) | Pasireotide et ses dérivés pharmaceutiquement acceptables (SIGNIFOR) | |
LU91624I2 (fr) | Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS®) | |
LU91757I2 (fr) | Denosumab et ses dérivés pharmaceutiquement acceptables (PROLIA®) | |
LU93096I2 (fr) | Evolocumab et ses dérivés pharmaceutiquement acceptables (repatha) | |
IS2599B (is) | 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólín og lyfjafræðilega viðurkenndar afleiður þess | |
LU92745I2 (fr) | Nétupitant/Palonosétron et leurs dérivés pharmaceutiquement acceptables (AKYNZEOr) | |
LU92182I2 (fr) | Dapagliflozine et ses sels pharmaceutiquement acceptables | |
ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
DK1556385T3 (da) | Heterocyclocarboxamid-derivater | |
DK1551802T3 (da) | Indol-3-svovlderivater | |
ATE467631T1 (de) | Chinuclidinamidderivate | |
IS7720A (is) | Píperidín-N-oxíð-afleiður | |
ATE438644T1 (de) | Chinazolinderivate |